Neuroprotective effect of resveratrol prophylaxis on experimental retinal ischemic injury

作者：Vin Anita P; Hu Hanbo; Zhai Yougang; Von Zee Cynthia L; Logeman Andrew; Stubbs Evan B Jr; Perlman Jay I; Bu Ping^*

来源：Experimental Eye Research, 2013, 108: 72-75.

DOI：10.1016/j.exer.2012.11.022

• resveratrol
• retinal ischemic reperfusion injury
• electroretinography
• neuroprotection

The purpose of the present study was to investigate whether systemically administered resveratrol can protect against acute retinal ischemic reperfusion injury. Two groups of adult male Sprague Dawley rats (n = 6 per group) were used for this study. Resveratrol (30 mg/kg) or an equal volume of vehicle (30% Solutol HS 15 in 0.9% saline) was administered daily for 5 days via intraperitoneal injection. On the third day of treatment, retinal ischemic injury was induced by elevation of intraocular pressure for 45 min. Prior to resveratrol administration and one-week following ischemic insult, retinal function was measured by scotopic electroretinography (ERG). Retinas were harvested and morphologically analyzed one week after ischemic insult. ERG a- and b-wave amplitudes were significantly reduced following ischemic reperfusion injury. Resveratrol treatment attenuated ischemic-induced loss of retinal function. In control vehicle-treated rats, ischemic reperfusion injury elicited marked thinning of inner retinal layers. Resveratrol prophylactic treatment reduced ischemia-mediated thinning of the whole retina and in particular the inner retinal layers. Therefore, resveratrol may have therapeutic value for the management of retinal ischemic disorders.

• 出版日期2013-3